- Home
- BGLWW vs BIAF Comparison
BGLWW vs BIAF Comparison
Compare BGLWW & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLWW
- BIAF
- Stock Information
- Founded
- BGLWW N/A
- BIAF 2014
- Country
- BGLWW United Kingdom
- BIAF United States
- Employees
- BGLWW N/A
- BIAF N/A
- Industry
- BGLWW Metal Mining
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BGLWW Basic Materials
- BIAF Health Care
- Exchange
- BGLWW Nasdaq
- BIAF Nasdaq
- Market Cap
- BGLWW 10.7M
- BIAF 12.2M
- IPO Year
- BGLWW N/A
- BIAF 2022
- Fundamental
- Price
- BGLWW N/A
- BIAF $0.27
- Analyst Decision
- BGLWW
- BIAF Hold
- Analyst Count
- BGLWW 0
- BIAF 1
- Target Price
- BGLWW N/A
- BIAF N/A
- AVG Volume (30 Days)
- BGLWW N/A
- BIAF 11.4M
- Earning Date
- BGLWW N/A
- BIAF 08-13-2025
- Dividend Yield
- BGLWW N/A
- BIAF N/A
- EPS Growth
- BGLWW N/A
- BIAF N/A
- EPS
- BGLWW N/A
- BIAF N/A
- Revenue
- BGLWW N/A
- BIAF $8,809,228.00
- Revenue This Year
- BGLWW N/A
- BIAF N/A
- Revenue Next Year
- BGLWW N/A
- BIAF $20.00
- P/E Ratio
- BGLWW N/A
- BIAF N/A
- Revenue Growth
- BGLWW N/A
- BIAF 78.40
- 52 Week Low
- BGLWW N/A
- BIAF $0.16
- 52 Week High
- BGLWW N/A
- BIAF $2.99
- Technical
- Relative Strength Index (RSI)
- BGLWW N/A
- BIAF 47.98
- Support Level
- BGLWW N/A
- BIAF $0.26
- Resistance Level
- BGLWW N/A
- BIAF $0.36
- Average True Range (ATR)
- BGLWW 0.00
- BIAF 0.05
- MACD
- BGLWW 0.00
- BIAF 0.00
- Stochastic Oscillator
- BGLWW 0.00
- BIAF 20.34
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.